Too fast to stay on track? Shorter time to first anti-retroviral regimen is not associated with better retention in care in the French Dat'AIDS cohort.

by L Cuzin, L Cotte, C Delpierre, C Allavena, M-A Valantin, D Rey, P Delobel, P Pugliese, F Raffi, A Cabié, Dat’AIDS Study group
Published 2019-01-01

Derivation and internal validation of a mortality risk index for aged people living with HIV: The Dat'AIDS score.

by Maxime Hentzien, Cyrille Delpierre, Pascal Pugliese, Clotilde Allavena, Christine Jacomet, Marc-Antoine Valantin, André Cabié, Lise Cuzin, David Rey, Firouzé Bani-Sadr, Moustapha Dramé, Dat’Aids Study Group
Published 2018-01-01

CMV+ Serostatus Associates Negatively with CD4:CD8 Ratio Normalization in Controlled HIV-Infected Patients on cART.

by Isabelle Poizot-Martin, Clotilde Allavena, Claudine Duvivier, Carla Eliana Cano, Francine Guillouet de Salvador, David Rey, Pierre Dellamonica, Lise Cuzin, Antoine Cheret, Bruno Hoen, Dat'AIDS Study Group
Published 2016-01-01

Antiretroviral therapy as a risk factor for chronic kidney disease: Results from traditional regression modeling and causal approach in a large observational study.

by Lise Cuzin, Pascal Pugliese, Clotilde Allavena, David Rey, Catherine Chirouze, Firouzé Bani-Sadr, André Cabié, Thomas Huleux, Isabelle Poizot-Martin, Laurent Cotte, Corinne Isnard Bagnis, Philippe Flandre, Dat’AIDS study group
Published 2017-01-01

Effectiveness and tolerance of single tablet versus once daily multiple tablet regimens as first-line antiretroviral therapy - Results from a large french multicenter cohort study.

by Laurent Cotte, Tristan Ferry, Pascal Pugliese, Marc-Antoine Valantin, Clotilde Allavena, André Cabié, Isabelle Poizot-Martin, David Rey, Claudine Duvivier, Antoine Cheret, Pierre Dellamonica, Pierre Pradat, Jean-Jacques Parienti, Dat’AIDS study group
Published 2017-01-01

Higher rates of HBsAg clearance with tenofovir-containing therapy in HBV/HIV co-infection.

by Pierre Gantner, Laurent Cotte, Clotilde Allavena, Firouzé Bani-Sadr, Thomas Huleux, Claudine Duvivier, Marc-Antoine Valantin, Christine Jacomet, Véronique Joly, Antoine Chéret, Pascal Pugliese, Pierre Delobel, André Cabié, David Rey, Dat’AIDS Study Group
Published 2019-01-01

Missed opportunities of HIV pre-exposure prophylaxis in France: a retrospective analysis in the French DAT’AIDS cohort

by C. Lions, O. Cabras, L. Cotte, T. Huleux, A. Gagneux-Brugnon, A. Makinson, A. Cabié, B. Bonnet, C. Duvivier, L. Hocqueloux, E. Cua, A. Cheret, L. Hustache-Mathieu, V. Obry-Roguet, C. Jacomet, I. Poizot-Martin, the DAT’AIDS STUDY GROUP
Published 2019-03-01

Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination

by Victor Virlogeux, Fabien Zoulim, Pascal Pugliese, Isabelle Poizot-Martin, Marc-Antoine Valantin, Lise Cuzin, Jacques Reynes, Eric Billaud, Thomas Huleux, Firouze Bani-Sadr, David Rey, Anne Frésard, Christine Jacomet, Claudine Duvivier, Antoine Cheret, Laurent Hustache-Mathieu, Bruno Hoen, André Cabié, Laurent Cotte, the Dat’AIDS Study Group
Published 2017-12-01

Antiretroviral exposure and comorbidities in an aging HIV-infected population: The challenge of geriatric patients.

by Clotilde Allavena, Matthieu Hanf, David Rey, Claudine Duvivier, Firouze BaniSadr, Isabelle Poizot-Martin, Christine Jacomet, Pascal Pugliese, Pierre Delobel, Christine Katlama, Véronique Joly, Christian Chidiac, Nathalie Dournon, Dominique Merrien, Thierry May, Jacques Reynes, Amandine Gagneux-Brunon, Catherine Chirouze, Thomas Huleux, André Cabié, François Raffi, Dat’AIDS study group
Published 2018-01-01